Webinar: Driving PGx Adoption – Proven Implementations to Reduce ADRs by 30% (The PREPARE Study)

This webinar, Driving PGx Adoption: Proven Implementations to Reduce ADRs by 30% (The PREPARE Study), presented in partnership with GenXys, will be led by industry experts Dr. George Patrinos, Professor and Head of Laboratory at the University of Patras and Editor-in-Chief of The Pharmacogenomics Journal, Dr. Sara Rogers, President of the American Society for Pharmacovigilance and Clinical Assistant Professor at Texas A&M University, and Dr. Richard Turner, Director – Physician in Genomic Sciences at GSK.